Clinical trials

  • DAPAGLIFLOZIN for Chronic kidney disease | Kidney failure | Heart failure
  • IANALUMAB for Systemic lupus erythematosus
  • GARETOSMAB for Fibrodysplasia ossificans progressiva
  • DELAFLOXACIN for Pseudomonas aeruginosa bacteremia
  • furmonertinib for Non-small cell lung cancer (EGFR- or HER2-mutant) | HER2-positive non-small cell lung cancer | Metastatic non-small cell lung cancer
  • Teclistamab for Relapsed/refractory multiple myeloma
  • LONAPEGSOMATROPIN for Achondroplasia
  • AMIVANTAMAB for Head and neck squamous cell carcinoma
  • MIRODENAFIL DIHYDROCHLORIDE for Alzheimer's disease
  • DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) for Pertussis
  • DEXAMFETAMINE SULFATE for Amphetamine use disorder | Opioid use disorder
  • ARBACLOFEN for Autism spectrum disorder